Finance

Lists
ECG:NYSE
Everus Construction Group Inc
$105.14
-0.57%
(-0.60) 1D
Oct 21, 1:16:56 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ECG...
Open
$108.07
High
$109.72
Low
$104.24
Mkt. cap
5.37B
Avg. vol.
445.32K
Volume
211.45K
P/E ratio
21.15
52-wk high
$171.58
52-wk low
$78.14
EPS
$4.97
Shares outstanding
51.06M
No. of employees
9K
Open
$108.07
High
$109.72
Low
$104.24
Mkt. cap
5.37B
Avg. vol.
445.32K
Volume
211.45K
P/E ratio
21.15
52-wk high
$171.58
52-wk low
$78.14
EPS
$4.97
Shares outstanding
51.06M
No. of employees
9K
News stories
From web sources and news partners
About Everus Construction Group Inc
CEO-
Employees9.4K
Founded2024
HeadquartersBismarck, North Dakota, United States
SectorConstruction
Websiteeverus.com
Analyst ratings
Based on 6 analysts giving stock ratings to ECG in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ECG in the last 3 months.
Highest
Current $105.14
$200.00 (+90.23%)
Average
$176.00 (+67.40%)
Lowest
$152.00 (+44.58%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Osha
Guggenheim
Buy
Reiterated
$184.00
+75%
10/09/2026
Brent Thielman
Oppenheimer
Buy
Maintained
$200.00
+90.2%
10/05/2026
Kurt Yinger
D.A. Davidson
Buy
Initiated
$168.00
+59.8%
08/24/2026
Manish Somaiya
Cantor Fitzgerald
Hold
Reiterated
$152.00
+44.6%
08/12/2026
Sergey Glinyanov
Freedom Capital Markets
Buy
Upgraded
$180.00
+71.2%
08/06/2026
Brian Brophy
Stifel Nicolaus
Buy
Maintained
$172.00
+63.6%
08/05/2026
Ian Zaffino
Oppenheimer
Buy
Reiterated
$180.00
+71.2%
05/07/2026
Austin Wang
GLJ Research
Hold
Initiated
$141.00
+34.1%
04/20/2026
Next call in 14 days
Wed, Nov 4, 5:30 PM
Fiscal period
Q3 2026
- / $1.34
Revenue / Est. (USD)
- / 1.18B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
986.82M
1.01B
1.04B
1.23B
Cost of goods sold
862.60M
893.97M
906.22M
1.05B
Cost of revenue
862.60M
893.97M
906.22M
1.05B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
51.84M
19.93M
53.04M
67.95M
Operating expense
51.84M
48.63M
53.04M
71.15M
Total operating expenses
914.44M
942.59M
959.27M
1.12B
Operating income
72.38M
68.88M
77.68M
111.77M
Other non operating income
3.44M
3.48M
799.00K
604.00K
EBT including unusual items
77.59M
73.99M
78.57M
113.29M
EBT excluding unusual items
77.29M
73.76M
78.82M
112.39M
Income tax expense
20.62M
18.71M
20.25M
29.40M
Effective tax rate
26.57%
25.29%
25.78%
25.95%
Other operating expenses
-
-
-
-
Net income
56.98M
55.28M
58.32M
83.89M
Net profit margin
5.77%
5.47%
5.62%
6.81%
Earnings per share
1.11
1.08
1.14
1.64
Interest and investment income
1.37M
1.72M
2.32M
1.33M
Interest expense
-5.44M
-5.01M
-4.62M
-4.63M
Net interest expenses
-4.07M
-3.30M
-2.30M
-3.30M
Depreciation and amortization charges
-
28.70M
-
-
EBITDA
79.67M
76.37M
85.76M
123.79M
Gain or loss from assets sale
-1.46M
-829.00K
-1.97M
-1.58M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps